Tugarinov V, Zvi A, Levy R, Hayek Y, Matsushita S, Anglister J
Department of Structural Biology, The Weizmann Institute of Science, Rehovot, 76100, Israel.
Structure. 2000 Apr 15;8(4):385-95. doi: 10.1016/s0969-2126(00)00119-2.
The protein 0.5beta is a potent strain-specific human immunodeficiency virus type 1 (HIV-1) neutralizing antibody raised against the entire envelope glycoprotein (gp120) of the HIV-1(IIIB) strain. The epitope recognized by 0.5beta is located within the third hypervariable region (V3) of gp120. Recently, several HIV-1 V3 residues involved in co-receptor utilization and selection were identified.
Virtually complete sidechain assignment of the variable fragment (Fv) of 0.5beta in complex with the V3(IIIB) peptide P1053 (RKSIRIQRGPGRAFVTIG, in single-letter amino acid code) was accomplished and the combining site structure of 0.5beta Fv complexed with P1053 was solved using multidimensional nuclear magnetic resonance (NMR). Five of the six complementarity determining regions (CDRs) of the antibody adopt standard canonical conformations, whereas CDR3 of the heavy chain assumes an unexpected fold. The epitope recognized by 0.5beta encompasses 14 of the 18 P1053 residues. The bound peptide assumes a beta-hairpin conformation with a QRGPGR loop located at the very center of the binding pocket. The Fv and peptide surface areas buried upon binding are 601 A and 743 A(2), respectively, in the 0.5beta Fv-P1053 mean structure. The surface of P1053 interacting with the antibody is more extensive and the V3 peptide orientation in the binding site is significantly different compared with those derived from the crystal structures of a V3 peptide of the HIV-1 MN strain (V3(MN)) complexed to three different anti-peptide antibodies.
The surface of P1053 that is in contact with the anti-protein antibody 0.5beta is likely to correspond to a solvent-exposed region in the native gp120 molecule. Some residues of this region of gp120 are involved in co-receptor binding, and in discrimination between different chemokine receptors utilized by the protein. Several highly variable residues in the V3 loop limit the specificity of the 0.5beta antibody, helping the virus to escape from the immune system. The highly conserved GPG sequence might have a role in maintaining the beta-hairpin conformation of the V3 loop despite insertions, deletions and mutations in the flanking regions.
蛋白质0.5β是一种强效的、具有毒株特异性的1型人类免疫缺陷病毒(HIV-1)中和抗体,它是针对HIV-1(IIIB)毒株的整个包膜糖蛋白(gp120)产生的。0.5β识别的表位位于gp120的第三个高变区(V3)内。最近,确定了几个参与共受体利用和选择的HIV-1 V3残基。
完成了0.5β可变片段(Fv)与V3(IIIB)肽P1053(单字母氨基酸编码为RKSIRIQRGPGRAFVTIG)复合物的几乎完整的侧链归属,并使用多维核磁共振(NMR)解析了0.5β Fv与P1053复合物的结合位点结构。抗体的六个互补决定区(CDR)中有五个采用标准的典型构象,而重链的CDR3呈现出意想不到的折叠。0.5β识别的表位包含P1053的18个残基中的14个。结合的肽呈现出β-发夹构象,其中QRGPGR环位于结合口袋的正中心。在0.5β Fv-P1053平均结构中,结合时Fv和肽的掩埋表面积分别为601 Å和743 Ų。与HIV-1 MN毒株的V3肽(V3(MN))与三种不同抗肽抗体的晶体结构相比,P1053与抗体相互作用的表面更广泛,且结合位点中V3肽的方向明显不同。
与抗蛋白抗体0.5β接触的P1053表面可能对应于天然gp120分子中的一个溶剂暴露区域。gp120该区域的一些残基参与共受体结合以及该蛋白所利用的不同趋化因子受体之间的区分。V3环中的几个高度可变残基限制了0.5β抗体的特异性,有助于病毒逃避免疫系统。尽管侧翼区域存在插入、缺失和突变,但高度保守的GPG序列可能在维持V3环的β-发夹构象中起作用。